Literature DB >> 4051538

Plasma concentrations after oral or intramuscular vitamin K1 in neonates.

A W McNinch, C Upton, M Samuels, M J Shearer, P McCarthy, J H Tripp, R L'E Orme.   

Abstract

One hundred and seven healthy, breast fed infants received 1 mg vitamin K1 either at birth (orally or intramuscularly) or with the first feed (orally). Venous blood samples collected in the next 24 hours were assayed for plasma vitamin K1. In babies given the vitamin orally at birth, the peak median concentration (73 ng/ml) occurred at four hours. By 24 hours median plasma concentrations had fallen to 23 ng/ml and 35 ng/ml in the groups fed vitamin K1 at birth or with the first feed, respectively; this difference was not, however, significant. Plasma concentrations after intramuscular injection exceeded those in the oral groups at all comparable times, with a peak median concentration of 1781 ng/ml at 12 hours falling to 444 ng/ml at 24 hours. Since median plasma vitamin K1 concentrations 24 hours after oral administration were some 100 times and 1000 times greater than previously estimated adult and newborn values respectively, this study supports giving vitamin K1 orally at birth to well, mature babies to protect against early haemorrhagic disease of the newborn. Further studies are needed to determine the optimum dose for protection over subsequent weeks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051538      PMCID: PMC1777471          DOI: 10.1136/adc.60.9.814

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Hemorrhage in the newborn and vitamin K prophylaxis.

Authors:  K W WEFRING
Journal:  J Pediatr       Date:  1962-11       Impact factor: 4.406

2.  Role of feeding and vitamin K in hypoprothrombinemia of the newborn.

Authors:  W J Keenan; T Jewett; H I Glueck
Journal:  Am J Dis Child       Date:  1971-04

3.  Absorption and excretion of an oral dose of tritiated vitamin K1 in man.

Authors:  M J Shearer; P Barkhan; G R Webster
Journal:  Br J Haematol       Date:  1970-03       Impact factor: 6.998

4.  Vitamin K1 for all newborn babies.

Authors:  P M Dunn
Journal:  Lancet       Date:  1982-10-02       Impact factor: 79.321

Review 5.  High-performance liquid chromatography of K vitamins and their antagonists.

Authors:  M J Shearer
Journal:  Adv Chromatogr       Date:  1983

6.  Fatal intracranial hemorrhage in a normal infant secondary to vitamin K deficiency.

Authors:  P A Lane; W E Hathaway; J H Githens; R D Krugman; D A Rosenberg
Journal:  Pediatrics       Date:  1983-10       Impact factor: 7.124

7.  Delayed presentation of haemorrhagic disease of the newborn.

Authors:  D Forbes
Journal:  Med J Aust       Date:  1983-08-06       Impact factor: 7.738

8.  Hemorrhagic disease of the newborn. Breast feeding as a necessary factor in the pathogenesis.

Authors:  J M Sutherland; H I Glueck; G Gleser
Journal:  Am J Dis Child       Date:  1967-05

9.  Plasma vitamin K1 in mothers and their newborn babies.

Authors:  M J Shearer; S Rahim; P Barkhan; L Stimmler
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

10.  The content of phylloquinone (vitamin K1) in human milk, cows' milk and infant formula foods determined by high-performance liquid chromatography.

Authors:  Y Haroon; M J Shearer; S Rahim; W G Gunn; G McEnery; P Barkhan
Journal:  J Nutr       Date:  1982-06       Impact factor: 4.798

View more
  27 in total

1.  Vitamin K and childhood cancer.

Authors:  D Hull
Journal:  BMJ       Date:  1992-08-08

2.  Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.

Authors:  E A Cornelissen; L A Kollée; R A De Abreu; J M van Baal; K Motohara; B Verbruggen; L A Monnens
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

3.  Vitamin K and childhood cancer.

Authors:  A W Kelsall
Journal:  BMJ       Date:  1992-10-24

Review 4.  Neonatal haemostasis.

Authors:  B Gibson
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

5.  Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness.

Authors:  Alison Busfield; Andrew McNinch; John Tripp
Journal:  Arch Dis Child       Date:  2007-05-30       Impact factor: 3.791

6.  Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom.

Authors:  J Handel; J H Tripp
Journal:  BMJ       Date:  1991-11-02

Review 7.  The neonatal coagulation system and the vitamin K deficiency bleeding - a mini review.

Authors:  Ewald Pichler; Ludwig Pichler
Journal:  Wien Med Wochenschr       Date:  2008

8.  Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn.

Authors:  K Stoeckel; P H Joubert; J Grüter
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

9.  Vitamin K prophylaxis in the newborn.

Authors:  A H Sutor; U Göbel; R V Kries; W Künzer; G Landbeck
Journal:  Blut       Date:  1990-05

Review 10.  Childhood cancer: improved prospects for survival but is prevention possible?

Authors:  A W Craft
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.